CDH1 Sequencing and Deletion/Duplication

Understand what CDH1 Sequencing and Deletion/Duplication signals

LOINC codes: 21652-3, 50398-7, 53037-8, 8266-9, 96973-3
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for CDH1 Sequencing and Deletion/Duplication

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

CDH1 Sequencing and Deletion/Duplication

Laboratory: Quest Diagnostics
Test code: 92568
Specimen: Blood
Fasting: Not stated
LOINC: 21652-3, 50398-7, 53037-8, 8266-9, 96973-3
Turnaround: Set up: Tues, Thurs, Sat

Laboratory assay overview

Germline mutations in the CDH1 (E-cadherin gene) gene have been reported in families with a hereditary predisposition to breast cancer and gastric cancer. Sequencing and deletion/duplication analyses of the CDH1 gene will identify individuals at risk for CDH1-related cancers.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 92568

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.